País: Reino Unido
Língua: inglês
Origem: HMA (Heads of Medicines Agencies)
clenbuterol hydrochloride 25 mg/ml
Reveta Handel und Forschung GmbH
QR03CC13
Oral liquid
Clenbuterol
Horses
2012-09-26
Issued: December 2012 AN: 01219/2011 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Equipulmin 25 micrograms/ml syrup for horses. (AT, ES, HU, IE, IT, UK) Equipulmin vet. 25 micrograms/ml syrup for horses. (FI, SE) Equipulmin vet. (DK) Equipulmin 22 micrograms/ml syrup for horses (FR) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance Clenbuterol hydrochloride 25 micrograms (corresponding to 22 micrograms clenbuterol) Preservatives: Methyl parahydroxybenzoate (E218) 2.02 mg Propyl parahydroxybenzoate 0.26 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Syrup Clear colourless syrup 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of respiratory disease in horses where it is considered that airway obstruction due to bronchospasm and/or accumulation of mucus is a contributing factor, and improved mucociliary clearance is desirable. To be used alone or as adjuvant therapy. Issued: December 2012 AN: 01219/2011 Page 2 of 5 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active substance or any of the excipients. Do not use in horses with known cardiac disease. For use during pregnancy or lactation see section 4.7. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS In cases accompanied by bacterial infection the administration of antimicrobial agents is r Leia o documento completo